参考文献/References:
[1]ESCOUBAS P, DIOCHOT S, CORZO G. Structure and pharmacology of spider venom neurotoxins [J]. Biochimie, 2000, 82(9/10):893-907.
[2]ESCOUBAS P, BOSMANS F. Spider peptide toxins as leads for drug development [J]. Expert Opinion on Drug Discovery, 2007, 2(6): 823-883.
[3]LIANG S P. An overview of peptide toxins from the venom of the Chinese bird spider Selenocosmia huwena Wang [=Ornithoctonus huwena (Wang)][J]. Toxicon, 2004, 43(5): 575 -585.
[4]CHATRATH S T, CHAPEAUROUGE A, LIN Q, et al. Identification of novel proteins from the venom of a cryptic snake Drysdalia coronoides by a combined transcriptomics and proteomics approach [J]. Journal Proteome Research, 2011, 10(2): 739-750.
[5]RUIMING Z, YIBAO M, YAWEN H, et al. Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components [J]. BMC Genomics, 2010, 11: 452.
[6]DIEGO-GARCIA E, PEIGNEUR S, CLYNEN E, et al. Molecular diversity of the telson and venom components from Pandinus cavimanus (Scorpionidae Latreille 1802): Transcriptome, venomics and function [J]. Proteomics, 2012, 12(2): 313-328.
[7]REMIGIO E A,DUDATF J R. Evolution of ecological specialization and venom of a predatory marine gastropod [J]. Molecular Ecology, 2008, 17(4): 1156-1162.
[8]ZHANG Y Q, CHEN J J, TANG X, et al. Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis [J]. Zoology (Jena), 2009, 113(1): 10-18.
[9]DIEGO-GARCI E, PEIGNEUR S, PEIGNEUR S, et al. Venom components from Citharischius crawshayi spider (Family Theraphosidae): exploring transcriptome, venomics, and function [J]. Cellular and Molecular Life Sciences, 2010, 67(16): 2799-2813.
[10]HARRIOTT A M, GOLD M S. Contribution of primary afferent channels to neuropathic pain [J]. Current Pain and Headache Reports, 2009, 13(3): 197-207.
[11]AMIR R, ARGOFF C E, BENNETT G J, et al. The role of sodium channels in chronic inflammatory and neuropathic pain [J]. Journal of Pain, 2006, 7 (Suppl5 ):1-29.
[12]梁海勇,李骞,陈金军. 蜘蛛毒素研究进展[J]. 检验医学与临床, 2013, 10(19): 2612-2613.
[13]浦飞飞,尹松,王晓英. 蜘蛛毒素的生物学活性研究进展[J].中国药理学通报, 2014, 30(12):1651-1654.
[14]HU Z T, ZHOU X, CHEN J, et al. The venom of the spider Selenocosmia jiafu contains various neurotoxins acting on voltage-gated ion channels in rat dorsal root ganglion neurons [J]. Toxins(Basel), 2014, 6(3):988-1001.
[15]邱方,刘艳红,姜雨鸽,等. 用于膜片钳研究的大鼠背根神经节细胞急性分离技术的改良[J]. 北京医学, 2012, 34(8):719-722.
[16]VON HEIJNE G. Patterns of amino acids near signal-sequence cleavage sites [J]. European Journal of Biochemistry, 1983, 133(1): 17-21.
[17]QIAO G F , LI B Y, ZHOU Y H , et al. Characterization of persistent TTX-R Na+ currents in physiological concentration of sodium in rat visceral afferents [J]. International Journal of Biological Sciences, 2009, 5(3): 293-297.
[18]CATTERALL W A. Voltage-gated sodium channels at 60: structure, function and pathophysiology [J]. Journal of Physiology, 2012, 590(11): 2577-2589.
[19]FABER C G, LAURIA G, MERKIES I S, et al. Gain-of-function Nav1.8 mutations in painful neuropathy [J]. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(47):19444-19449.
[20]ROWE A H, XIAO Y, ROWE M P, et al. Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin [J]. Science, 2013, 342(6157):441-446.
[21]董志敏,张宝石,关荣霞,等. 全长cDNA文库的构建方法[J]. 中国农学通报,2006,22(2):51-55.
[22]CHEN J J, DENG M C, HE Q Y, et al. Molecular diversity and evolution of cystine knot toxins of the tarantula Chilobrachys jingzhao [J]. Cellular and Molecular Life Sciences, 2008, 65(15): 2431-2444.
[23]CHOW C Y, CRISTOFORI-ARMSTRONG B, UNDHEIM E A, et al. Three peptide modulators of the human voltage-gated sodium channel 1.7, an important analgesic target, from the venom of an australian tarantula [J]. Toxins (Basel), 2015, 7(7): 2494-2513.
[24]DENG M C, KUANG F, SUN Z H, et al. Jingzhaotoxin-IX, a novel gating modifier of both sodium and potassium channels from Chinese tarantula Chilobrachys jingzhao[J]. Neuropharmacology, 2009, 57(2): 77-87.
[25]THEILE J W, CUMMINS T R. Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes [J]. Frontiers in Pharmacology, 2011, 2(54):54.
[26]ZULIANI V, RAPALLI A, PATEL M K, et al. Sodium channel blockers: a patent review (2010-2014) [J]. Expert Opinion on Therapeutic Patents, 2015, 25(3):279-290.